|6.34 -0.02 (-0.31%)||11-28 13:28|
|Targets||6-month :||8.51||1-year :||9.25|
|Resists||First :||7.29||Second :||7.92|
|Supports||First :||6.28||Second :||5.22|
|MAs||MA(5) :||6.5||MA(20) :||6.94|
|MA(100) :||8.21||MA(250) :||10.67|
|MACD||MACD :||-0.4||Signal :||-0.4|
|%K %D||K(14,3) :||13||D(3) :||16.4|
|52-week||High :||20.95||Low :||5.69|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ HSDT ] has closed above bottom band by 14.1%. Bollinger Bands are 62.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
|If tomorrow:||Open lower||Open higher|
|High:||6.52 - 6.55||6.55 - 6.57|
|Low:||6.25 - 6.29||6.29 - 6.33|
|Close:||6.3 - 6.36||6.36 - 6.42|
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.
|Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
|Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
|Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
|Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
|Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
|Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
|Shares Out||0 (M)|
|Shares Float||1 (M)|
|Held by Insiders||651840 (%)|
|Held by Institutions||0 (%)|
|Shares Short||79 (K)|
|Shares Short P.Month||0 (K)|
|EPS Est Next Qtrly||0|
|EPS Est This Year||0|
|EPS Est Next Year||0|
|Book Value (p.s.)||0|
|Profit Margin||0 %|
|Operating Margin||-2 %|
|Return on Assets (ttm)||93.7 %|
|Return on Equity (ttm)||-57.3 %|
|Qtrly Rev. Growth||792000 %|
|Gross Profit (p.s.)||-21.96|
|Sales Per Share||-129.13|
|Qtrly Earnings Growth||-11.9 %|
|Operating Cash Flow||0 (M)|
|Levered Free Cash Flow||-11 (M)|
|Price to Book value||0|
|Price to Sales||-0.05|
|Price to Cash Flow||1.77|
|Dividend Pay Date||Invalid DateTime.|
|Ex-Dividend Date||Invalid DateTime.|